Chronic Kidney Disease: a Risk Factor for Cardiovascular Disease
Overview
Authors
Affiliations
The goal of risk stratification of CVD inpatients with CKD is to lead to effective and early intervention and to prevent the adverse outcomes associated with this complex multisystem disease that is characteristic of growing number of patients with CKD in the general population and of patients receiving dialysis therapy or kidney transplantation. By 2030, there will be 2.24 million patients with ESRD in the United States, and approximately 1.3 million of these cases of ESRD will be caused by diabetes mellitus. Thus, CVD in this high-risk population presents a challenge for the nephrology and the cardiology community.
Shriya A, Pawar V, Paul A Curr Diabetes Rev. 2024; 21(6):93-101.
PMID: 38994615 DOI: 10.2174/0115733998305019240702095537.
Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges.
Chen F, Chen N, Xia C, Wang H, Shao L, Zhou C Cell Transplant. 2023; 32:9636897231164251.
PMID: 37013255 PMC: 10074620. DOI: 10.1177/09636897231164251.
Qi Y, He J, Pan M, Yan J Int Urol Nephrol. 2022; 54(12):3179-3191.
PMID: 35689780 DOI: 10.1007/s11255-022-03192-7.
Nakajima T, Shibasaki I, Sawaguchi T, Haruyama A, Kaneda H, Nakajima T J Clin Med. 2019; 8(10).
PMID: 31581569 PMC: 6832285. DOI: 10.3390/jcm8101576.
Genome-Wide Analysis Studies and Chronic Kidney Disease.
Piras D, Zoledziewska M, Cucca F, Pani A Kidney Dis (Basel). 2018; 3(3):106-110.
PMID: 29344505 PMC: 5757562. DOI: 10.1159/000481886.